SEC 13F Intelligence

Dekabank Deutsche Girozentrale / ABT

Dekabank Deutsche Girozentrale’s Abbott Laboratories Position

Does Dekabank Deutsche Girozentrale own Abbott Laboratories (ABT)? Yes — 2.54M shares worth $263M (+0.43% of its 13F portfolio) as of Q1 2026.

Position Value
$263M
Q1 2026
Shares
2.54M
% of Portfolio
+0.43%
Quarters Held
29
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $57MQ4 ’18Q1 ’19: $51MQ2 ’19: $122MQ3 ’19: $120MQ4 ’19: $108MQ4 ’19Q1 ’20: $104MQ2 ’20: $122MQ3 ’20: $199MQ1 ’21: $362MQ1 ’21Q2 ’21: $272MQ3 ’21: $227MQ4 ’21: $265MQ1 ’22: $222MQ1 ’22Q2 ’22: $200MQ3 ’22: $180MQ4 ’22: $214MQ1 ’23: $197MQ1 ’23Q2 ’23: $297MQ3 ’23: $268MQ4 ’23: $300MQ1 ’24: $303MQ1 ’24Q2 ’24: $276MQ3 ’24: $285MQ4 ’24: $290MQ1 ’25: $349MQ1 ’25Q2 ’25: $344MQ3 ’25: $338MQ4 ’25: $299MQ1 ’26: $263MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.54M$263M+0.43%
Q4 20252.54M$299M+0.52%
Q3 20252.54M$338M+0.57%
Q2 20252.54M$344M+0.61%
Q1 20252.66M$349M+0.68%
Q4 20242.54M$290M+0.54%
Q3 20242.54M$285M+0.53%
Q2 20242.62M$276M+0.50%
Q1 20242.66M$303M+0.56%
Q4 20232.72M$300M+0.62%
Q3 20232.73M$268M+0.62%
Q2 20232.75M$297M+0.67%
Q1 20232.00M$197M+0.50%
Q4 20221.95M$214M+0.57%
Q3 20221.85M$180M+0.53%
Q2 20221.85M$200M+0.58%
Q1 20221.84M$222M+0.54%
Q4 20211.86M$265M+0.64%
Q3 20211.89M$227M+0.64%
Q2 20212.33M$272M+0.79%
Q1 20213.01M$362M+1.20%
Q3 20201.88M$199M+0.88%
Q2 20201.38M$122M+0.77%
Q1 20201.28M$104M+0.80%
Q4 20191.23M$108M+0.66%
Q3 20191.46M$120M+0.74%
Q2 20191.45M$122M+0.61%
Q1 2019760.0K$51M+0.31%
Q4 2018807.6K$57M+0.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of ABT.